Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$35.61 - $76.23 $1.31 Million - $2.81 Million
-36,850 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$57.56 - $82.54 $592,062 - $849,006
-10,286 Reduced 21.82%
36,850 $2.58 Million
Q4 2021

Feb 07, 2022

SELL
$72.5 - $100.68 $2.38 Million - $3.3 Million
-32,766 Reduced 41.01%
47,136 $3.67 Million
Q3 2021

Nov 08, 2021

BUY
$90.24 - $124.05 $371,157 - $510,217
4,113 Added 5.43%
79,902 $7.63 Million
Q2 2021

Aug 05, 2021

BUY
$93.66 - $139.27 $555,497 - $826,010
5,931 Added 8.49%
75,789 $9.42 Million
Q1 2021

May 11, 2021

BUY
$116.57 - $155.01 $214,255 - $284,908
1,838 Added 2.7%
69,858 $9.21 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $615,290 - $877,875
6,177 Added 9.99%
68,020 $9.01 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $224,520 - $314,088
3,079 Added 5.24%
61,843 $6.31 Million
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $306,179 - $509,383
5,492 Added 10.31%
58,764 $5.11 Million
Q1 2020

May 13, 2020

SELL
$37.9 - $104.44 $375,058 - $1.03 Million
-9,896 Reduced 15.67%
53,272 $3.09 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $843,620 - $1.08 Million
10,863 Added 20.77%
63,168 $5.84 Million
Q3 2019

Nov 13, 2019

BUY
$90.37 - $122.49 $76,904 - $104,238
851 Added 1.65%
52,305 $4.73 Million
Q2 2019

Aug 12, 2019

BUY
$89.51 - $118.04 $573,490 - $756,282
6,407 Added 14.22%
51,454 $6.07 Million
Q1 2019

May 14, 2019

BUY
$61.98 - $96.5 $430,017 - $669,517
6,938 Added 18.21%
45,047 $3.9 Million
Q4 2018

Feb 13, 2019

BUY
$56.04 - $82.66 $224,047 - $330,474
3,998 Added 11.72%
38,109 $2.41 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $1.36 Million - $2.27 Million
28,114 Added 468.8%
34,111 $2.69 Million
Q2 2018

Aug 13, 2018

BUY
$37.84 - $69.96 $226,926 - $419,550
5,997 New
5,997 $359,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Northeast Investment Management Portfolio

Follow Northeast Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.